Literature DB >> 19339163

[Posterior urethral valves: prenatal diagnosis, neonatal data and outcome].

M Trellu1, A-L Adra, J-F Mouba, C Lopez, M Averous, R-B Galifer, F Dalla-Vale, L Ichay, D Morin.   

Abstract

AIM OF THE STUDY: To evaluate the impact of prenatal diagnosis on the epidemiology and outcome of children with posterior urethral valves (PUV), considering that today termination of pregnancy may be proposed in the most severe cases. PATIENTS AND METHODS: Forty-three cases of patients with PUV were diagnosed between 1998 and 2007 in the Languedoc-Roussillon region. In this study, we detailed the prenatal data and postnatal outcome of those patients with a mean follow-up period of 7.6 years.
RESULTS: Medical interruption of pregnancy was performed in 15 severe cases. One death in utero was also observed. Twenty-seven patients were managed postnatally and one child died during the neonatal period because of lung hypoplasia. For the 26 remaining patients at the end of the follow-up period, 5 had mild renal insufficiency with a creatinine clearance calculated with the Schwartz formula of less than 80 ml/min/1.73 m2. One reached end-stage renal failure at the age of 7 years. Proteinuria and hypertension were rare. DISCUSSION AND
CONCLUSION: Today, because of the increase in medical termination of pregnancy in the most severe cases, most of the children born alive with PUV experienced a better renal prognosis when compared with previous data. Prenatal diagnosis and therapeutic progress significantly modified the epidemiology and outcome of this disease. Nevertheless, the best predictor of renal outcome remains renal function at 1 year of age.

Entities:  

Mesh:

Year:  2009        PMID: 19339163     DOI: 10.1016/j.arcped.2009.02.006

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  1 in total

1.  Renal impairment in children with posterior urethral valves.

Authors:  Jameela Abdulaziz Kari; Sherif El-Desoky; Youssef M K Farag; Youssef Farag; Hisham Mosli; Abdul-Malik Altyieb; Ahmad Al Sayad; Othman Radawi; Hosam Ghabra; Faten Basnawi; Ohood Bahrawi; Ajay Singh; Hassan Farsi
Journal:  Pediatr Nephrol       Date:  2012-12-24       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.